Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes.

Lin, Jiun-Nong; Lai, Chung-Hsu; Yang, Chih-Hui; Huang, Yi-Han

Lin, Jiun-Nong; Lai, Chung-Hsu; Yang, Chih-Hui; Huang, Yi-Han.

Afiliação

Lin JN; Division of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan jinoli@kmu.edu.tw.
Lai CH; Department of Critical Care Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Yang CH; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Huang YH; Division of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.

Antimicrob Agents Chemother ; 63(5)2019 05.

Article em En | MEDLINE | ID: mdl-30782983

Assuntos

Chryseobacterium/efeitos dos fármacos; Chryseobacterium/genética; Fluoroquinolonas/farmacologia; DNA Girase/genética; DNA Girase/metabolismo; Testes de Sensibilidade Microbiana; Mutação/genética; RNA Ribossômico 16S/genética

Palavras-chave

Chryseobacterium gleum; Chryseobacterium indologenes; drug resistance; quinolone resistance-determining region

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluoroquinolonas / Chryseobacterium Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google